Company Filing History:
Years Active: 2022
Title: Xueshi Huang: Innovator in Pharmaceutical Chemistry
Introduction
Xueshi Huang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that aid in medical treatments. His innovative work has led to the creation of a unique compound that shows promise in promoting wound healing.
Latest Patents
Xueshi Huang holds a patent for an emodin succinyl ester compound, along with its preparation method and applications. This invention is characterized by its structure, which includes a Calkyl group. The preparation method is designed to be straightforward, allowing for efficient synthesis that saves time and reduces costs. Experimental results indicate that this compound is more effective in promoting the healing of diabetic wounds compared to traditional emodin.
Career Highlights
Huang is associated with Jiangsu Kanion Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His work has not only focused on the synthesis of new compounds but also on ensuring that these compounds are safe and effective for medical use. The emodin succinyl ester compound has demonstrated a remarkable blood fat-lowering effect, making it a valuable addition to diabetes treatment options.
Collaborations
Xueshi Huang has collaborated with colleagues such as Baofeng Yang and Wei Xiao, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.
Conclusion
Xueshi Huang's contributions to the field of pharmaceutical chemistry, particularly through his patented emodin succinyl ester compound, highlight his role as an innovator dedicated to improving medical treatments. His work exemplifies the impact of research and innovation in addressing health challenges.